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Abstract 
Tyrosine phosphorylation has been implicated in interleukin 2 (IL-2)-induced growth signaling and the phosphorylation levels are regulated by 
the balance of tyrosine kinase and tyrosine phosphatase activities. Here, we demonstrate the rapid activation of a leukocyte tyrosine phosphatase 
LC-PTP (HePTP) gene expression by IL-2 in an IL-2 dependent human T cell ILT-Mat. Accumulation of LC-PTPmRNA appeared at 1 h and peaked 
at 6 h after IL-2 stimulation, simultaneous with the Gl to early S phase, and the induction of LC-PTP mRNA did not require protein synthesis. 
LC-PTP protein increased approximately 6-fold at 8 h after IL-2 stimulation. Nuclear run-on assays showed that the induction of LC-PTP mRNA 
expresslon is mostly due to transcriptional activation. These data suggest hat LC-PTP is an early response gene and its protein seems to be a crucial 
molecule which regulates the tyrosine phosphorylation level during T cell proliferation. 
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1. Introduction 
Accumulating evidence suggests that tyrosine kinase 
activity is essential for some cellular responses, i.e. prolif- 
eration, differentiation, and transformation. In T-cells, 
IL-2 stimulation promotes the progression of competent 
cells from the Gl phase to the S phase and has been 
shown to result in increased tyrosine phosphorylation of 
cellular substrates; this is usually initiated by ~56”~ [l]. 
Protein tyrosine phosphatases (PTPs) reverse the ac- 
tion of PTKs by removal of the phosphotyrosyl groups 
from target proteins and thus have been thought to func- 
tion as a counter-regulator of PTKs. However, recent 
advances in characterization of PTPs reveal complicated 
cross-talk between PTPs and PTKs. Over-expression of 
cytoplasmic PTPlB can suppress the tumorigenesis of 
erbB2-transformed NIH3T3 cells [2], whereas overex- 
pression of transmembrane PTPcl enhances the tyrosine 
kinase (PTK) activity of C-SIC and leads to a transformed 
phenotype [3]. Importantly, CD45 dephosphorylates 
~56’“~ to activate its PTK [4] and also has some key role 
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in T-cell activation via TCR, which requires tyrosine 
phosphorylation events [5]. These findings strongly sug- 
gest some PTPs activate specific PTKs and specifically 
trigger increased protein tyrosine phosphorylation in in- 
tracellular signal transduction. It follows that PTPs must 
be strictly regulated while they actuate cellular responses 
to extracellular signals just as PTKs are. 
Recently, we and others cloned a nontransmembrane 
PTP cDNA (LC-PTP [6,7], HePTP [8]) which is preferen- 
tially expressed in T-cells and induced by some mitogens 
[6,8]. This particular expression pattern suggests LC- 
PTP may play a crucial role in T-cells. We further inves- 
tigated LC-PTP gene induction and its regulation follow- 
ing IL-2 stimulation. We report here that LC-PTP is an 
early response gene and the induction leads to increase 
of its protein. This strongly suggests LC-PTP seems to 
regulate tyrosine phosphorylation level of protein(s) cru- 
cial for T cell proliferation. 
2. Materials and methods 
2.1. Reagents and cell culture 
ILT-Mat cells were maintained in RPMI-1640 with 10% fetal calf 
serum (FCS) containing 400 U/ml IL-2 (kindly provided by Takeda 
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Chemical Pharmacy. Japan). For factor deprivation experiments, cells 
were washed twice, and resuspended without IL-2 for 30-36 h. Follow- 
ing IL-2 stimulation, RNA expression levels, nuclear un-on assay, cell 
cycle status, and protem synthesis were analyzed. For analysis of the 
effect of protein synthesis on LC-PTP gene expression, ILT-Mat cells 
were cultured with 10 ,ug/ml of cycloheximide (CHX) (Sigma). Human 
peripheral blood mononuclear cells (PBMC) were isolated from a nor- 
mal donor by FicoBHypaque centrifugation. The composition of 
PBMC populations, determined by indirect immunofluorescence with 
cell-sorter analysis, was 71.8% CD3’. 38.5% CD4’. 32.6% CD8’, 67.0% 
TCRc@, 17.2% CD19’. 2.8% IL-2R’. The CD3’ cells were enriched 
by the incubation in CD3 antibody-covered CELLector flasks (Applied 
Immune Sciences Inc., Menlo Park, CA) for 48 h following the instruc- 
tions of the manufacturer. The enriched T cells (90.2% CD3’. 0.3% 
CD19’, 26.6% IL-2R’) were activated by IL-2 after incubation in 10% 
FCS-RPMI-1640 for 24 h. 
2.2. Northern blot analysis 
Ten pg of the total RNAs extracted from ILT-Mat cells were sepa- 
rated in 1% agarose formaldehyde gels by electrophoresis and trans- 
ferred to nitrocellulose filters. The filters were hybridized with 32P- 
labeled various cDNA fragments as probes; the 0.6-kb 5’ region of the 
human LC-PTP cDNA clone [6], the 2.2-kb human full-length c-myc 
cDNA 191, the 0.3-kb human PTPlB cDNA fragment [7,10] and the 
/3-actin EDNA probe [ 111. The hybridization conditions were 50% for- 
mamide. 2 x SSC (1 x SSC is 150 mM NaCVlS mM trisodium citrate), 
2.5 x Denhart’s solution, 0.1% SDS, 2.5% dextran sulfate, and dena- 
tured salmon testes DNA (lOO&ml). The same blots were used to test 
the LC-PTP, c-myc, PTPlB and /?-actin transcripts under identical 
conditions. The amount of hybridization was quantified by scanning 
the autoradiographs with a densitometer (Model d1650, Bio-Rad) or 
laser densitometry using an NIH image program. 
2.3. Cell cycle unalysis 
The ILT-Mat cells processed under the above conditions were evalu- 
ated for cell cycle status following the modified protocol CycleTEST, 
Becton Dickinson [12]. The cells were fixed with ethanol for 30 min at 
-20°C washed, and incubated with 1 mg/ml of ribonuclease A for 30 
min at 37”C, followed by addition of an ice-cold solution containing 
propidium iodide to stain the nuclei (final propidium concentration. 
125 pg/ml). The fluorescence in each nucleus was measured with 
FACScan and the proportions of the cells in each phase of the cycle 
were determined by analysis with the computer program CellFIT (Bec- 
ton Dickinson). 
2.4. Nuclear run-on transcription assays 
A total of 1 x 10’ to 2.5 x 10’ ILT-Mat cells were suspended in 500 
~1 of lysis buffer (10 mM Tris pH 7.4,lO mM NaCl, 3 mM MgQ, 0.5% 
NP40). washed twice with lysis buffer, suspended in 100 ~1 of storage 
buffer (50 mM Tris pH 8.3, 40% glycerol, 5 mM MgCl,, 0.1 mM 
EDTA) and stored at -80°C. As essentially described by M.R. Stallcup 
et al. [13], 10 pg of linearized, denatured plasmid DNAs containing 
LC-PTP, c-myc and/I-actin cDNA fragments (described above) per slot 
were transferred to nitrocellulose using a slot blot apparatus (Hybri-slot 
Manifold, BRL), and prehybridized overnight in hybridization solution 
(50% Formamid, 5 x SSC. 50 mM Na-phosphate pH 6.5.1 x Denhardt 
and 250 pg/ml of salmon testis DNA). The nuclei were incubated with 
100 &i of [a-“P]UTP in reaction buffer (10 mM Tris pH 8.0, 5 mM 
M&l,. 300 mM KC1 and 5 mM ATP. CTP. GTP) and the newly 
synthesized RNA was extracted and hybridized in the same buffer at 
42°C for approximately 48 h. No distinct hybridization to plasmid 
DNA alone was detected on any of the filters (data not shown). Each 
transcript was scanned by laser densitometry and its gray scale unit was 
determined by NIH image program [14]. 
2.5. Antlbodles 
A region of the LC-PTP cDNA encoding amino acids loo-360 was 
isolated and cloned into the bacterial expression plasmid pMAL-cR1. 
Maltose binding protein (MAL) fusion protein was purified using am- 
ylose resin (NEB) and eluted using 10 mM maltose in accordance with 
manufacturer’s protocol. Anti-LC-PTP sera were generated in New 
Zealand white male rabbits usmg approximately 100 pg of the purified 
bacterial recombinant pMAL-LC-PTP fusion protein. 
2.6. Preparation of recombinant baculovirus and lysates from bacu- 
lovirus-infected insect cells 
The full-length LC-PTP gene was cloned as an XbaI 1.6 kb fragment 
into pBlueBac (Invitrogen). Recombinant baculoviruses encoding the 
LC-PTP gene were isolated by standard procedure using the kit from 
Invitrogen. SI9 cells were infected with recombinant or wild type bacu- 
loviruses, harvested 2days after infection, washed, and resuspended m 
lysis buffer, which consisted of 20 mM Tris-HC1 pH 7.6, 50 mM NaCI, 
1 mM dithiothreitol, 1% NP40 and 1 mM PMSF. 
2.7 Western blot analysts 
Human gastric cancer cell line JRST, T-cell leukemia cell lines Jurkat 
and ILT-Mat were washed and suspended in lOO@ of lysis buffer (100 
mM NaCI, 2 mM EDTA, 10 mM sodium orthovanadate, 1mM PMSF. 
1% NP40 and 50 mM Tris pH 7.2). The protein concentrations of these 
lysates were calculated with Protein Assay (Bio-Rad) and each lysate 
was incubated for 2 h with 20 ~1 of anti-LC-PTP-agarose. Following 
extensive washing, immunoprecipitated proteins were subjected to 
SDS-PAGE and transferred to Immobilon PVDF (Millipore). The 
blots were incubated with blocking solution containing 3% BSA, 10 
mM Tris oH 8.2. 140 mM NaCl. and 0.01% NaN,. Then. thev were 
incubated-with 2’ pg/ml of anti-LC-PTP antibody “or pre-imm&zed 
rabbit IgG for 2 h in washing solution (150 mM NaCl, 10 mM Tris pH 
7.5 and 0.01% Tween 20) with 2% FCS, followed by an additional 1 h 
of incubation with alkaline phosphatase-conjugated monoclonal anti- 
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Fig. 1. Expressions of LC-PTP, c-myc, and PTPlB genes in ILT-Mat 
cells after IL-2 stimulation. After 36 h of IL-2 deprival, ILT-Mat cells 
were stimulated with IL-2 for various periods. The same total RNA 
samples from the ILT-Mat cells were loaded on 1% formaldehyde 
agarose gel and analyzed by Northern blot for LC-PTP, c-myc, and 
PTPlB transcripts. After the first autoradiography. the same filters 
were rehybridized with -‘*P-labeledp-actin cDNA probe which was used 
as a control. The positions of ribosomal RNA markers, which showed 
equal amount of RNA loaded (data not shown), are indicated to the 
right of the blots. 
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rabbit IgG antibody (Sigma). The blots were developed by a standard 
alkaline phosphatase method. 
2.8. Immunoprecip~tations 
Following starvation of ILT-Mat cells for 24 h in IL-2-depleted 
medium, the cells were washed twice with methionine-free medium 
containing dialyzed 10% FCS, then metabolically labeled for 8 h with 
[?5]cysteine and [??.]methionine (sp.act. 1,000 Ci/mmol, NEN). Prior 
to the harvest, IL-2 was added to the medium at the indicated periods. 
Whole-cell lysates were prepared (see above) and immunoprecipitated 
with 20 ~1 of 50% suspension of anti-LC-PTP-agarose. Following ex- 
tensive washing, resulting complexes were subjected to SDS-PAGE 8% 
gel electrophoresis. The gels were fixed, treated with ENLIGHTEN- 
ING (NEN) and dried for autoradiography. 
3. Results 
3.1. LC-PTP mRNA expression is induced by IL-2 
The human ILT-Mat is an IL-Zdependent T-cell line 
carrying human T-cell leukemia virus type I; the cells 
express the IL-2Ro$? heterodimer [15]. After 30-36 h 
deprival of IL-2, the cells (viability > 90%) were stimu- 
lated by saturation with IL-2. RNA blot analysis showed 
that IL-2 was capable of inducing LC-PTP mRNA. The 
induction was detectable at 1 h and peaked at 9 h after 
IL-2 addition (Figs. 1 and 3A). As reported previously 
[16], IL-2 has a similar effect on the steady-state level of 
c-myc mRNA and the induced mRNA was already de- 
tectable at 30 min following the stimulation, peaked at 
2 h, and decreased slowly thereafter (Figs. 1 and 3A). In 
contrast, the closely related nontransmembrane PTPlB 
transcripts did not vary greatly (Fig. 1). We also ob- 
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Fig. 3. (A) Expressions of LC-PTP and c-myc genes in ILT-Mat cells 
for long periods after IL-2 stimulation. The same total RNA samples 
loaded on 1% formaldehyde agarose gel were analyzed by Northern 
blot for LC-PTP, c-myc, and/?-actin transcripts. The positions of ribo- 
somal RNA markers, which showed equal amount of RNA loaded 
(data not shown), are indicated to the right of the blots. (B) Cell cycle 
analysis of ILT-Mat cells after IL-2 treatment. Cells were harvested at 
various times after IL-2 addition, stained with propidium iodide, and 
analyzed by flow cytometry. The calculated percentages (means of two 
independent experiments) of Gl phase(o), S phase (m) and GUM phase 
(0) are plotted. 
Fig. 2. Induction of LC-PTP gene expression in normal T-cells after 
IL-2 stimulation. Normal T-cells were stimulated with IL-2 for 3 h, 
after culture in anti-CD3coated flask for 2 days, following by an 
additional 1 day of culture in 10% FCS-RPMI-1640 (B). Mononuclear 
cells from the same donor were stimulated by IL-2 for 3 h without CD3 
stimulation (A). The same total RNA samples were loaded on 1% 
formaldehyde agarose gel and analyzed by Northern blot for LC-PTP 
transcripts. After the first autoradiography, the same filters were rehy- 
bridized with “P-labeled /&actin cDNA probe which was used as a 
control. 
served that LC-PTP mRNA expression was induced at 
3 h by IL-2 in normal human CD3’ cells, which had been 
activated by an anti-CD3 antibody (Fig. 2). 
Forty-five percent of the ILT-Mat cells starved for 36 
h were arrested in the Gl phase of the cell cycle shown 
as time zero in Fig. 3B. After IL-2 stimulation, they 
began to replicate DNA within 5-6 h, showed a maxi- 
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Fig. 4. Expression of p40’“~p’p. Western blot analysis of p4O ” p’p in Sl9 cells (A) (lanes: 1 and 3, Sf9 cells infected with baculovirus expressing full-length 
LC-PTP cDNA; 2 and 4, Sl9 cells infected with wild-type baculovnus), or human cell lines (B) (lanes: 1, Jurkat; 2 and 4, ILT-Mat; 3 and 5, JRST). 
Each cell lysate (400 pg) was immuno-precipitated with anti-LC-PTP-agarose and the precipitates were loaded on 10% SDS-PAGE gels. Control 
serum showed no distinctive band (lanes: 3 and 4 in (A); lanes: 4 and 5 in (B)). (C) Metabolic labeling of p40’c-ptp after IL-2 stimulation. ILT-Mat 
cells were deprived of IL-2 for 24 h, then washed twice with methionine-free medium, and incubated with addition of [‘Slcysteine and [?S]methionine 
for 8 h without IL-2 (0 h). At the indicated periods (l-8 h) prior to harvest, IL-2 (400 U/ml) was added. Each fraction (3 x lo6 cells) was 
immunoprecipitated with the anti-LC-PTP-agarose and the precipitates were loaded on a 8% SDS-PAGE gel, treated with ENLIGHTENING and 
dried for autoradiography. Minor bands above p40’c~p’p arenonspecific, which was confirmed by Western blot analysis (bottom panel), and a slight 
decrease of p40’c-p’p at 6 h after IL-2 stimulation was not seen in other two independent experiments. Molecular weight of marker proteins are given 
in kDa. 
mum percentage of cells in S phase at 21 h. and thereafter 
reentered Gl (Fig. 3B). Although the cells appeared to 
grow in a less synchronous manner compared with fi- 
broblast cells, the induction of LC-PTP gene by IL-2 
seems to occur at Gl to early S phase, while the c-myc 
gene was induced simultaneously with an accumulation 
of cells at the early Gl phase (Fig. 3). 
3.2. LC-PTP protein level is elevated by IL-2 
The open reading frame of LC-PTP cDNA encodes a 
- 40-kDa protein composed of 360 amino acids [6]. In 
order to identify the product of LC-PTP mRNA 
(p40’c~p’p) expressed in human T-cells, we generated the 
anti-p40’c~P’P antibody (see section 2). The antibody de- 
tected p40 lc ptp _ in baculovirus-infected St9 cells express- 
ing full-length LC-PTP cDNA (lane I), whereas no dis- 
tinctive band appeared in the cells infected with wild-type 
virus (lane 2) (Fig. 4A). Consistent with the previous 
data showing exclusive expression of LC-PTP mRNA in 
hematopoietic cells [6,8], p40’c-p’p was detected in the he- 
matopoietic cells; Jurkat (lane 1) and ILT-Mat (lane 2), 
but not in non-hematopoietic cells; JRST (lane 3) (Fig. 4B). 
ILT-Mat cells were deprived of IL-2 for 24 h, then the 
washed cells were metabolically labeled with 
[35S]methionine and [35S]cysteine for 8 h. At the indicated 
periods prior to harvest, IL-2 was added to the cells. The 
increase of p40’c~p’p a peared at 4 h and reached approx- 
imately 6-fold at 8 h after IL-2 addition (Fig. 4C). West- 
ern blot analysis also showed LC-PTP protein increased 
at 6 h after IL-2 stimulation (Fig. 4C, bottom). Thus, the 
transcriptional elevation of LC-PTP gene leads to in- 
crease of p401c-p’p level in ILT-Mat cells. 
3.3. Mechanism of IL-2-induced LC-PTP transcriptional 
elevation 
A nuclear run-on assay was used to determine whether 
LC-PTP transcripts are increased in ILT-Mat cells be- 
cause of elevation of the transcriptional activity. Nuclei 
were prepared from cells 0, 1, 3, and 6 h after exposure 
to IL-2. The nascent transcription of the LC-PTP gene 
was elevated (approximately 2-fold) at 1 h and elevated 
greatly at 6 h (approximately 6-fold) after IL-2 stimula- 
tion (Fig. 5), suggesting that the induction of LC-PTP 
transcripts following IL-2 stimulation was mostly due to 
transcriptional activation. As reported previously [ 171, 
the c-myc gene transcription was transiently activated 
(approximately 2-fold) at 3 h after IL-2 stimulation. 
The effect of CHX treatment on LC-PTP mRNA lev- 
els was analyzed to determine whether the elevation of 
LC-PTP mRNA by IL-2 stimulation in ILT-Mat cells 
requires protein synthesis. After 36 h of IL-2 deprival, 
the induction of LC-PTP gene by IL-2 was not blocked 
by the addition of CHX (Fig. 6A). Thus, protein synthe- 
sis is not necessarily required for its induction by IL-2. 
c, 
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Fig. 5. Run-on analysis of IL-2 treated ILT-Mat cells. Nuclei were 
isolated, and nascent RNA transcripts were radiolabeled and hybrid- 
ized with a nitrocellulose filter onto which various plasmid DNAs 
(LC-PTP, c-myc, and /Sactin) had been slotted (top). Representative 
data of nascent RNA transcripts of LC-PTP (A) and c-myc (0) genes 
plotted against time after IL-2 treatment in two independent experi- 
ments (bottom). Each signal was scanned by laser densitometry and the 
intensity was shown by gray scale unit which was determined using NIH 
scan image program. 
Interestingly, CHX treatment enhanced LC-PTP mRNA 
expression at 6 h after CHX addition (Fig. 6B). This 
gives us an idea that LC-PTP mRNA levels seem to be 
actively controlled post-transcriptionally by some pro- 
tein(s). 
4. Discussion 
We and others have identified a LC-PTP (HePTP) 
cDNA which is preferentially expressed in T-cells [6,8]. 
We present here, for the first time, evidence that IL-2 
activates LC-PTP mRNA expression in ILT-Mat cells, 
suggesting that LC-PTP gene is an important target for 
the IL-2 signal. Following IL-2 stimulation, the LC-PTP 
transcripts increased simultanously with an acctmmla- 
tion of cells at the Gl to early S phase. The period of the 
LC-PTP gene activation is longer and delayed in com- 
parison to c-fos and c-myc gene expressions [ 18,161: tran- 
scription of LC-PTP peaked about 6-9 h after IL-2 stim- 
ulation and continued for several hours. Importantly, 
transcription of a closely-related nontransmembrane 
PTPlB was not altered by IL-2 stimulation (Fig. l), and 
transmembrane PTP (CD45) was not either (unpub- 
lished observation, M. Sekiya and M. Adachi). This sug- 
2‘ 
gests that LC-PTP gene is specifically activated by IL-2 
and implies a biological significance for LC-PTP in T- 
cell activation. It is also noteworthy that IL-Zinduced 
LC-PTP gene activation was also seen in normal T cells 
activated by CD3 (Fig. 2). 
We also demonstrate, for the first time, in this study 
that the product of LC-PTP gene is a protein with a 
molecular weight of 40 kDa (p40’c~p’p). In addition, met- 
abolic protein labeling of p40’c-p’p showed distinctly that 
p40’c~p’p was increased approximately 6-fold at 8 h after 
IL-2 stimulation. 
In order to clarify the mechanisms of increase of LC- 
PTP mRNA and protein levels, following points were 
tested. An increase in the level of a given mRNA in a cell 
can result from increased transcription of the message, 
decreased egradation of the synthesized mRNA, or sta- 
bilization of the mRNA. The transcriptional rate of the 
LC-PTP gene, as assessed by nuclear run-on transcrip- 
tion assays, was significantly elevated after IL-2 stimula- 
tion (Fig. 5). We also examined the half-lives of LC-PTP 
mRNA in IL-2-induced proliferating and IL-Zdeprived 
quiescent ILT-Mat cells. Two independent experiments 
showed that they were not significantly altered; the half- 
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Fig. 6. Effect of CHX on LC-PTP transcripts in ILT-Mat cells. (A) 
LC-PTP transcripts of ILT-Mat cells treated with IL-2 and CHX simul- 
taneously after 36 h of IL-2 deprival. (B) LC-PTP transcripts in ILT- 
Mat cells treated with CHX. The same total RNA samples from ILT- 
Mat cells at the indicated periods were loaded on 1% formaldehyde 
agarose gel and analyzed by Northern blot for LC-PTP transcripts. 
After the first autoradiography, the same filters were rehybridized with 
‘2P-labeled B-actin cDNA probe which was used as a control. 
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lives of LC-PTP mRNA in proliferating and quiescent 
ILT-Mat cells were approximately 2.7 h and 2.2 h, re- 
spectively (data not shown), suggesting that stabilization 
of LC-PTP mRNA is unlikely as an explanation for the 
induction. It is noteworthy that the induction of the LC- 
PTP gene by IL-2 was not blocked, but super-induced in 
the presence of cycloheximide (Fig. 6) suggesting that 
the LC-PTP gene expression level may be regulated by 
some protein(s) with short half-lives. Taken together, the 
induction of LC-PTP mRNA is mostly due to transcrip- 
tional activation, but unknown regulation by some pro- 
tein(s) also should be considered. 
The fact that protein synthesis is not necessary for the 
IL-Zinduced LC-PTP gene to be activated strongly sug- 
gests that the LC-PTP gene is a primary target of IL-2 
signaling. Together with the kinetic analysis of LC-PTP 
mRNA, we conclude that the LC-PTP gene is one of 
(immediate) early genes which are characterized as nu- 
clear proto-oncogenes or genes associated with cell cycle 
progression, such as c-fos, c-jun, c-myc, cyclins, and cdc2 
kinase, whose gene expressions are independent of pro- 
tein synthesis. Recently, a mitogen-induced gene (PAC- 
1) has been cloned from human T cells [19] and the 
predicted protein sequence has a similarity with 
phosphatases induced by mitogens or heat shock in 
human homolog (CLlOO) [20], fibroblast (3CH134) [21], 
and a vaccinia virus-encoded serine-tyrosine phosphat- 
ase (VHl) [22]. These (immediate) early response genes 
encode proteins which have minimal active site for PTP, 
but are different from typical PTPs exemplified by 
PTPlB or LC-PTP, suggesting that they may constitute 
a new structural family of PTP In this context, LC-PTP 
is an unique early-response PTP. 
Recently, a novel PTK itk (IL-2-inducible T-cell ki- 
nase) gene has been identified; its transcripts were found 
to be preferentially expressed in T-cells and increased 
7-fold in 2 h in parallel with IL-2Ra transcripts after 
IL-2 stimulation [23]. Since LC-PTP is preferentially ex- 
pressed in T cells and similarly induced by IL-2, it is of 
great interest o investigate whether p40’c~p’p is associated 
with ~72”~. In any case, our data provide novel insights 
into IL-2 induced signaling pathways. 
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